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Summary
 Aim Tumours situated in the region of the base of the skull are at the limits of possibility for radical re-
section and in patients with malignant tumours it is necessary to use combined methods of treat-
ment. The purpose of this paper is to evaluate the early results of combined treatment tumours of 
the base of the skull.
 Materials/Methods Between 1994 and 2004 68 patients with malignant tumours of the base of the skull and 10 with be-
nign tumours were treated by an interdisciplinary group. Treatment included surgery, radiother-
apy, and chemotherapy.
 Results After a period of post operative observation (median length 19 months), 32 patients with malig-
nant tumours were without recurrence of disease, 8 lived with the tumour, 21 died as a result of 
disease progression and 4 died of other causes. Information was unavailable for 3 patients. Among 
10 patients with benign tumours, 5 lived without symptoms of disease and 5 with the tumour.
 Conclusions Because of the limited possibilities regarding radical removal of malignant tumours in the re-
gion of the base of the skull, combined treatment using radiotherapy, surgery and, in some cas-
es, chemo therapy is standard. Use of aggressive treatments gave local control in about half the pa-
tients though further observation is necessary in order to assess later oncological results.
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BACKGROUND
Radical treatment of tumours at the base of the skull is chal-
lenging and methods such as surgery and radiotherapy have 
only recently become possible. [1,2]. Experience of skull 
base surgery is further limited by short patient observation 
periods and low numbers of treated patients.
Surgery to the base of the skull is carried out by a team of 
specialists from various disciplines, enabling the best com-
binations of techniques and experience to be used to safe-
ly complete these complicated and risky operations. In the 
case of malignant tumours, however, it is rare that surgical 
resection is the only treatment. This is a result of the com-
plex anatomy of the base of the skull and the fact that many 
organs and functionally important structures are situated 
nearby. For this reason, in the majority of patients with ma-
lignancies of the base of the skull, a combination of surgery, 
radiotherapy and chemotherapy is applied in order to ob-
tain the best oncological results.
AIM
The purpose of this paper is to present the early results of 
our combined treatment for cancers of the base of the skull 
in a group of patients treated by a multidisciplinary team.
MATERIALS AND METHODS
Beween 1994 & 2002, 241 patients were operated for tu-
mours of the base of the skull. All patients were operated 
by a team consisting of neurosurgeons, otolaryngologists, 
general surgeons and oncological surgeons. The patients 
were divided into groups. Group A consisted of 96 patients 
diagnosed with malignant tumours. Of these, 68 patients 
received combined treatment and underwent 80 surgical 
procedures for the purposes of removing the tumours. 29 
patients received pre-operative radiotherapy (including 8 
cases of radio-chemotherapy) and 7 received chemotherapy. 
Benign tumours were diagnosed in 133 people and of these 
10 received combined treatment (group B). This group un-
derwent 19 operations. 2 patients were treated with radia-
tion pre-operatively and 8 post-operatively. Table 1 shows 
histological diagnoses.
For all patients, treatment was planned by a team consisting 
of surgeons of various specialities. Additionally, planning for 
patients with malignant tumours included radiotherapy and 
chemotherapy specialists. For benign tumours the opinion 
of oncologists was sought, prior to treatment planning, de-
pending on the clinical situation. 51 operations were of a sal-
vage character after failure of earlier treatment. 28 patients 
with a malignancy could not be treated using the combined 
therapy. In 13 cases this was because of the type of tumour, 
in 6 the general state of the patient was the reason for exclu-
sion and 4 other patients refused further treatment.
Patient data was collected and stored in a database which 
was used to evaluate the results of treatment.
RESULTS
In group A, radical resection en bloc accounted for 12% of 
operations, total macroscopic resection of the entire speci-
men with free resection margins was possible in 72% of cas-
es and in the remainder of operations only partial removal 
of the tumour was possible. In group B, en bloc resection 
was not used and total macroscopic resection accounted 
for 11% of operations.
Table 2 shows the extent of resections and post-operative 
complications.
The most frequently observed complication concerned 
problems with wound healing and was seen after 8 oper-
ations. During the post-operative period one patient died. 
After surgery, 30 patients from group A received addition-
al radiation doses of 60 Gy while 6 received chemotherapy. 
In group B, post-operative radiotherapy was used in 8 pa-
tients. Three patients suffered further complications from 
radiotherapy.
Data concerning oncological and functional status were avail-
able for 75 of the 78 patients selected for the study. The me-
dian observation time was 19 months. Table 3 shows the re-
sults of treatment.
DISCUSSION
Possibilities for the safe and effective treatment of tumours 
of the base of the skull now exist, thanks to multidiscipli-
nary teams of interested specialist surgeons in this area. The 
beginning of this type of work was surgery of neuromas of 
Diagnosis Number of patients
Squamous cell carcinoma  24
Basal cell carcinoma  7
Adenocarcinoma  5
Adenoid cystic carcinoma  4
Other carcinoma  14
Sarcoma  14
Juvenile angiofi broma  7
Meningioma  2
Hypophyseal adenoma  1
Table 1. Histological fi ndings.
Group A Group B
Radical resection en bloc  10  0
Total macroscopic resection  58  2
Partial/Subtotal resection  12  17
Total number of operations  80  19
Number of complications  17  4
Deaths in postoperative period  1  0
Table 2. Resections and complications.
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the acoustic nerve performed by House and Hitselberger 
in the 1960s [3]. During the 1970s, teams and centres for 
surgery of the base of the skull were founded. These cen-
tres developed rules for cooperation and techniques for re-
section and reconstruction. Also in this period, scientifi c as-
sociations were formed, of surgeons, oncologists and other 
specialists involved in the treatment process, with the pur-
pose of developing treatments for the area of the base of the 
skull [1]. At the same time, improvements in radiological 
technique made it possible to deliver radiation within very 
accurate areas and with very exact dosing with only limited 
damage to healthy structures. The equipment needed for 
gamma surgery became more common, and also linear ac-
celerators were introduced, which allowed for stereotactic 
irradiation [2]. It became possible to deliver radiation very 
precisely and to irradiate safely tumours in every location.
Despite gigantic progress, treatment of cancers of the base 
of the skull remains very diffi cult; the introduction of or-
ganizational ideas and the mastering of new techniques re-
quires a great deal of time and effort. For these reasons, the 
number of interdisciplinary teams with meaningful experi-
ence remains limited and the observation periods for treat-
ed patients remain relatively short. This has resulted in sig-
nifi cantly greater information about the technical aspects 
of treatment than about late results [4,5].
The possibilities for carrying out radical resections in the 
region of the base of the skull are limited by the number of 
important structures found in this area. There are almost no 
limits to the surgical techniques which may be employed, 
though the risks may be diffi cult to accept. Therefore, op-
timal treatment should combine conservative and surgical 
methods in order to ensure the best results while limiting 
the risks. It is possible to live a long time with a slow-grow-
ing benign tumour and, in such cases, quality of life comes 
fi rst. Surgical treatment should not involve the risk of seri-
ous reductions to patients’ quality of life and treatment com-
bined with radiotherapy can ensure adequate local control 
of the tumour for many years [6]. In the case of malignant 
tumours, non-radical surgery gives no greater advantages 
than conservative treatment. Therefore, possibility of rad-
ical resection should be evaluated and the patient should 
be asked if he accepts the risks. If he does not, use of radi-
otherapy and chemotherapy will be appropriate.
Radical resection en bloc at the base of the skull is diffi -
cult to achieve. The teams that operate only upon patients 
in whom radical resection is thought to be possible, can 
achieve it in around 80% of operations [7]. In our group, 
we advise surgery also when preoperative diagnosis suggests 
that total macroscopic removal of the tumour with clear re-
section margins will be possible insteated of radical ‘en bloc’ 
resection. With use of such qualifying critera, radical resec-
tion en bloc was possible in 12% of operations. However, 
even after resection en bloc, it is rare to obtain suffi ciently 
wide margins of healthy tissue to avoid the use of comple-
mentary treatments. In the material we present, in only 2 
patients the initial treatment was surgery and observation 
was recommended in these cases. Radiosurgical techniques 
can now be used as initial treatments for patients with ma-
lignant tumours of the base of the skull owing to improve-
ments in availability and technological advances. The size 
of the tumour is a limitation. The post-treatment obser-
vation period is relatively short, as with surgical methods, 
but local control, survival and the number of complications 
are better than among patients treated surgically [2,8,9]. 
However, a comparison of these methods is practically impos-
sible due to different qualifi cation criteria. Chemotherapy 
is used routinely in certain cancers of the base of the skull 
(nasopharyngeal cancers, esthesioblastoma), but not as the 
only method and in the majority of patients should be used 
only within the areas of research protocols [10].
Treatment of malignant tumours of the base of the skull is 
therefore dependent on combined therapies, among which, 
surgery is one of the stages. Evaluation of the results of 
treatment and identifi cation of prognostic factors is very 
diffi cult because the clinical material contains a variety of 
tumours in different locations. Small differences in the tu-
mours localization result in major variations in the diffi cul-
ty, risks and complications of surgery. Surgical and radio-
logical techniques must, therefore, be individualized. The 
possibility of attaining 40–60% symptom free 5 year survival 
is the result of progress in conservative and surgical meth-
ods and their skilful application through the experiences 
of many specializations [1,5,7,11–13].
CONCLUSIONS
Treatment of tumours of the base of the skull is challeng-
ing for both the head and neck surgeon and radiotherapist. 
Due to very inconvenient localizations of these tumours com-
bined treatment (surgery + radiotherapy+– chemotherapy) 
gives the best results.
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Group A Group B
Survived – symptom free  32  5
Survived – disease stationary  1  2
Survived – disease progressing  7  3
Died as a result of disease progression  21  0
Died of other causes  4  0
Total number of patients  65  10
Table 3. Results of treatment.
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